NCT06657222 First in Human Study of TUB-030 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06652555 The Incidence and Risk Factors of Central Nervous System Adverse Events of Lorlatinib in Patients with ALK-positive Advanced Non-small Cell Lung Cancer: a Real-world Study Status NOT_YET_RECRUITING Phase N/A
NCT06644495 Post-Market Surveillance Study of ALK-Positive Advanced NSCLC Participants Treated With Iruplinalkib Status NOT_YET_RECRUITING Phase N/A
NCT06620835 Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib Status RECRUITING Phase PHASE2
NCT06576635 LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients Status RECRUITING Phase NA
NCT06570317 Nintedanib for the Prevention of Radiation Pneumonia in Unresectable NSCLC Status RECRUITING Phase N/A
NCT06552000 Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer Status NOT_YET_RECRUITING Phase NA
NCT06534762 Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study Status RECRUITING Phase PHASE2
NCT06532591 Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC Status RECRUITING Phase PHASE2
NCT06502249 Modulatory Effect of Prodigiosin or Pioglitazone on TIME and the Crosstalk to Immune-Checkpoint Protein(s) Status NOT_YET_RECRUITING Phase N/A
NCT06496009 The Clinical Characteristics and Efficacy of Immunotherapy in First-line PD-L1-negative Advanced NSCLC Patients Status NOT_YET_RECRUITING Phase N/A
NCT06480136 SHR-A1921 Combined With Adebrelimab in the Treatment of Advanced NSCLC Who Failed the Previous Standard First-line Treatment Status NOT_YET_RECRUITING Phase PHASE2
NCT06479759 LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT06467383 A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced Status RECRUITING Phase N/A
NCT06465238 Clinical Study of SHR-A1921 or SHR-A2009 in Previously Treated Advanced NSCLC Status NOT_YET_RECRUITING Phase PHASE2
NCT06462963 OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT) Status RECRUITING Phase NA
NCT06457789 Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer Status RECRUITING Phase NA
NCT06448910 Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage III NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06431685 Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer Status RECRUITING Phase PHASE1